LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Biologics/Could Elevated Zinc, Copper Levels Cause Osteoarthritis?
Biologics

Could Elevated Zinc, Copper Levels Cause Osteoarthritis?

July 7, 2021 2 min read Premium comments

Advertisement

#osteoarthritis#rheumatoidarthritisSecondary

Could elevated levels of zinc or copper or both be a contributing cause to the onset of osteoarthritis (OA)? Using a novel genetic statistical method for inferring causation, a new study, “Genetically predicted circulating levels of copper and zinc are associated with osteoarthritis but not with rheumatoid arthritis,” appears in the July 1, 2021 edition of Osteoarthritis and Cartilage and provides evidence that, yes, elevated zinc or copper levels are not only correlated with OA incidence, they may also have a causal connection.

Native copper and Zinc / Source: Wikimedia Commons and Alchemist-hp

Kaixiong Ye, Ph.D., study co-author and assistant professor in the Department of Genetics | Institute of Bioinformatics at the University of Georgia explained to OTW that, “In previous epidemiological studies, the circulating levels of minerals, such as copper, zinc, iron, calcium, and magnesium, have been previously associated with the risk of osteoarthritis or rheumatoid arthritis. However, the circulating levels of minerals are correlated with other risk factors and influenced by the disease progression. In other words, these associations do not imply causality between these minerals and OA (or rheumatoid arthritis-RA).”

Using Mendelian Randomization to Infer Causation

“A novel method, called Mendelian randomization, is less affected by confounding and reverse causation, and thus more likely to infer causal relationships between a risk factor and a disease. In a nutshell, this method uses ‘genetically predicted mineral levels,’ instead of the ‘directly measured mineral levels.’ The genetically predicted levels are only controlled by genetic backgrounds and not influenced by lifestyle or disease status.”

“Genetically determined copper and zinc status were associated with OA, but not with RA,” said the authors. “Per standard deviation (SD) increment in copper increases the risk of OA and one of its subtypes, localized OA. Per standard deviation increment in zinc is positively associated with risks of OA, generalized OA, and unspecified OA. Additionally, per standard deviation increment in calcium decreases the risk of localized OA.”

Cut Copper and Zinc Levels to Treat OA?

“The genetically predicted levels of copper and zinc are associated with a higher risk of osteoarthritis. Copper and zinc likely play causal roles in the development of osteoarthritis. Reducing circulating levels of copper and zinc may be effective preventative or therapeutic approaches for osteoarthritis.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy